com_NN Summary_NNP financial_JJ statements_NNS Auditors_NNS statement_NN Auditors_NNS statement_NN to_TO the_DT members_NNS of_IN These_DT summary_NN Financial_NNP Statements_NNP are_VBP a_DT Basis_NN of_IN opinion_NN summary_NN of_IN information_NN in_IN the_DT Groups_NNS annual_JJ AstraZeneca_NNP PLC_NNP ,_, pursuant_JJ to_TO section_NN 251_CD We_PRP conducted_VBD our_PRP$ work_NN in_IN accordance_NN with_IN Financial_NNP Statements_NNP ,_, Directors_NNS Report_NNP and_CC of_IN the_DT Companies_NNS Act_NNP 1985_CD Bulletin_NNP 1999_CD 6_CD The_DT auditors_NNS statement_NN on_IN Directors_NNS Remuneration_NNP Report_NNP and_CC do_VB not_RB We_PRP have_VBP examined_VBN the_DT summary_NN Financial_NNP the_DT summary_NN financial_JJ statement_NN issued_VBN by_IN contain_VBP sufficient_JJ information_NN to_TO allow_VB for_IN as_RB full_JJ Statements_NNS set_VBN out_RP on_IN pages_NNS 28_CD to_TO 33_CD ._.
This_DT the_DT Auditing_NNP Practices_NNPS Board_NNP for_IN use_NN in_IN the_DT UK_NNP ._.
an_DT understanding_NN of_IN the_DT results_NNS and_CC state_NN of_IN statement_NN is_VBZ made_VBN solely_RB to_TO the_DT Companys_NNPS Our_PRP$ report_NN on_IN the_DT Groups_NNS full_JJ annual_JJ Financial_JJ affairs_NNS of_IN the_DT Group_NNP as_IN would_MD be_VB provided_VBN by_IN members_NNS ,_, as_IN a_DT body_NN ,_, in_IN accordance_NN with_IN Statements_NNP describes_VBZ the_DT basis_NN of_IN our_PRP$ audit_NN the_DT full_JJ annual_JJ Financial_NNP Statements_NNP ,_, Directors_NNS section_NN 251_CD of_IN the_DT Companies_NNS Act_NNP 1985_CD ._.
Our_PRP$ opinion_NN on_IN those_DT Financial_NNP Statements_NNP ._.
Report_NNP and_CC Directors_NNS Remuneration_NNP Report_NNP ._.
work_NN has_VBZ been_VBN undertaken_VBN so_RB that_IN we_PRP might_MD Shareholders_NNS requiring_VBG more_JJR detailed_JJ information_NN state_NN to_TO the_DT Companys_NNPS members_NNS those_DT matters_NNS Opinion_NNP have_VBP the_DT right_NN to_TO obtain_VB ,_, free_JJ of_IN charge_NN ,_, a_DT copy_NN we_PRP are_VBP required_VBN to_TO state_NN to_TO them_PRP in_IN such_PDT a_DT In_IN our_PRP$ opinion_NN the_DT summary_NN Financial_NNP of_IN the_DT Groups_NNS last_JJ full_JJ Annual_JJ Report_NNP and_CC Form_NN statement_NN and_CC for_IN no_DT other_JJ purpose_NN ._.
To_TO the_DT Statements_NNS are_VBP consistent_JJ with_IN the_DT full_JJ annual_JJ 20-F_JJ Information_NN ,_, available_JJ from_IN the_DT Secretary_NNP fullest_JJS extent_NN permitted_VBN by_IN law_NN ,_, we_PRP do_VBP not_RB Financial_JJ Statements_NNS ,_, the_DT Directors_NNS Report_NNP at_IN the_DT registered_JJ office_NN of_IN the_DT Company_NN ._.
accept_VB or_CC assume_VB responsibility_NN to_TO anyone_NN other_JJ and_CC the_DT Directors_NNS Remuneration_NNP Report_NNP of_IN than_IN the_DT Company_NN and_CC the_DT Companys_NNP AstraZeneca_NNP PLC_NNP for_IN the_DT year_NN ended_VBD The_DT summary_NN Financial_NNP Statements_NNP on_IN pages_NNS members_NNS as_IN a_DT body_NN ,_, for_IN our_PRP$ work_NN ,_, for_IN this_DT 31_CD December_NNP 2004_CD and_CC comply_VB with_IN the_DT 28_CD to_TO 33_CD were_VBD approved_VBN by_IN the_DT Board_NNP of_IN statement_NN ,_, or_CC for_IN the_DT opinions_NNS we_PRP have_VBP formed_VBN ._.
applicable_JJ requirements_NNS of_IN section_NN 251_CD of_IN Directors_NNS on_IN 27_CD January_NNP 2005_CD and_CC were_VBD signed_VBN the_DT Companies_NNS Act_NNP 1985_CD ,_, and_CC the_DT regulations_NNS on_IN its_PRP$ behalf_NN by_IN :_: Respective_JJ responsibilities_NNS of_IN Directors_NNS made_VBN thereunder_RB ._.
and_CC Auditor_NNP The_DT Directors_NNS are_VBP responsible_JJ for_IN preparing_VBG 27_CD January_NNP 2005_CD the_DT Annual_JJ Review_NNP 2004_CD in_IN accordance_NN with_IN applicable_JJ United_NNP Kingdom_NNP law_NN ._.
Our_PRP$ KPMG_NNP Audit_NNP Plc_NNP responsibility_NN is_VBZ to_TO report_VB to_TO you_PRP our_PRP$ opinion_NN Chartered_NNP Accountants_NNPS on_IN the_DT consistency_NN of_IN the_DT summary_NN Financial_NNP Registered_NNP Auditor_NNP Sir_NNP Tom_NNP McKillop_NNP ,_, Director_NNP Statements_NNP within_IN the_DT Annual_JJ Review_NNP 2004_CD 8_CD Salisbury_NNP Square_NNP with_IN the_DT full_JJ annual_JJ Financial_NNP Statements_NNP ,_, the_DT London_NNP EC4Y_NNP 8BB_NNP Directors_NNS Report_NNP and_CC the_DT Directors_NNS Remuneration_NNP Report_NNP ,_, and_CC its_PRP$ compliance_NN with_IN the_DT relevant_JJ requirements_NNS of_IN section_NN 251_CD of_IN the_DT Companies_NNS Act_NNP 1985_CD and_CC the_DT regulations_NNS made_VBD thereunder_RB ._.
We_PRP also_RB read_VBD the_DT other_JJ information_NN Jonathan_NNP Symonds_NNP ,_, Director_NNP contained_VBD in_IN the_DT summary_NN Annual_JJ Review_NNP and_CC consider_VB the_DT implications_NNS for_IN our_PRP$ report_NN if_IN we_PRP become_VBP aware_JJ of_IN any_DT apparent_JJ misstatements_NNS or_CC material_NN inconsistencies_NNS with_IN the_DT summary_NN Financial_NNP Statements_NNP ._.
